Healthtech Investors & VC Firms in China
120 firms in this list, with a median first check of $1M. 6 of them lead rounds. Generated from verified public data and updated continuously.
China Renaissance – Huaxing New Economy Funds
BeijingSeed–Growth
Chow Tai Fook Enterprises
Hong KongGrowth
CICC
BeijingGrowth–Late Stage
Co-Stone Capital
ShenzhenSeed–Growth
CPE
BeijingGrowth–Late Stage
DCP Capital
BeijingGrowth–Late Stage
Everbright Investments
Hong KongGrowth–Late Stage
Fosun RZ Capital
BeijingSeed–Growth
FountainVest Partners
Hong KongGrowth–Late Stage
Frees Fund
BeijingPre-Seed–Series B
Greater Bay Area Homeland Development Fund
Hong KongSeed–Growth
Haier Capital
QingdaoSeed–Growth
Haier HOPE / HCH innovation platform
QingdaoPre-Seed–Growth
HongShan Capital Group
BeijingSeed–Growth
Innoangel
BeijingPre-Seed–Series A
Jebsen Capital
Hong KongSeries A–Late Stage
Jeneration Capital
Grand Cayman, KySeries A–Growth
Lake Bleu Capital
Hong KongSeed–Growth
Lanchi Ventures
BeijingSeed
Plug and Play China
ShanghaiPre-Seed–Growth
SAIF Partners China
BeijingSeed–Growth
Sinovation Ventures Australia
MelbournePre-Seed
Tencent Holdings
ShenzhenSeed–Growth
Trustbridge Partners
ShanghaiSeries B–Late Stage
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.